Plasminogen activators in acute management of thrombosis
https://doi.org/10.15829/1560-4071-2013-3-81-84
Abstract
The paper focuses on the problem of intravascular thrombosis and the methods of its treatment. The data on haemostasis pathophysiology, which underlie the occurrence of acute ischemic events in humans, are presented, together with the data on the action mechanisms of fibrinolytic medications. The focus is on tenecteplase, as a modified agent which is more effective than the native tissue plasminogen activator or its closest derivatives.
About the Author
E. O. Taratukhin
N.I. Pirogov Russian National Medical Research University, Moscow, Russia
Russian Federation
Russian Federation
References
1. Lyusov V. A., Taratukhin E. O. New insight on Atherothrombosis. Russ J Cardiol, 2011; 2 (II):5–15. Russian (Люсов В. А., Таратухин Е. О. Новый взгляд на атеротромбоз. Российский кардиологический журнал, 2011; 2 (II):5–15).
2. Gordeev I. G., Taratukhin E. O., Shaydyuk O. Yu. Clinical Physiology of Clotting. M.: Silicea-Polygraph, 2013, 128p. Russian (Гордеев И. Г., Таратухин Е. О., Шайдюк О. Ю. Клиническая физиология гемостаза. М.: Силицея-Полиграф, 2013, 128 с.)
3. Declerck P. J., Gils A. Three decades of research on Plasminogen Activator Inhibitor-1: a multifaceted serpin. Semin Theromb Hemost, 2013; Mar 16.
4. Malaguarnera M., Vacante M., Russo C., et al. Lipoprotein (a) in cardiovascular diseases. Biomed Res Int, 2013: 650989.
5. Gallagher S., Jain A. K., Archbold R. A. Intracoronary thrombolytic therapy: a treatment option for failed mechanical thrombectomy. Catheter Cardiovasc Interv, 2012; 80 (5):835–7.
6. Agarwal S. K. Pharmacoinvasive therapy for acute myocardial infarction. Catheter Cardiovasc Interv., 2011; 78 (1):72–5.
7. Parsons M., Spratt N., Bivard A. et al. A randomized trial of tenecteplase vs alteplase for acute ischemic stroke. New England J Med, 2012; 366:1099–107.
8. Tapson V. F. Thrombolytic therapy for acute pulmonaty embolism. Semin Thromb Hemost, 2013; Mar 28.
9. Marcos-Contreras O. A., Ganguly K., Yamamoto A. et al. Clot penetration and retention by plasminogen activators promote fibrinolysis. Biochem Pharmacol, 2014; 85 (2):216–22.
10. Armstrong P. W., Gershlick A. H., Goldstein P. et al. Fibrinolysis or primary PCI in ST-segment myocardial infarction. N Engl J Med, 2013; Mar 10.
11. Steering Comittee. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Am Heart J, 2012; 163 (1):33–8.
12. Huber K. Optimizing reperfusion therapy in acute ST-elevation myocardial infarction by a pharmaco-invasive treatment approach in a well-organized network. Eur Heart J, 2012; 33 (10):1184–6.
13. Larson D. M., Duval S., Sharkey S. W. et al. Safety and efficacy of a pharmacoinvasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers. Eur Heart J, 2012; 33 (10):1232–40.
14. Crowder J. S., Hubble M. W., Gandhi S. et al. Prehospital administration of tenecteplase for ST-segment elevation myocardial infarction in a rural emergency medical services. Prehosp Emerg Care, 2011; 15 (4):499–505.
15. Welsh R. C., Westerhout C. M., Buller C. E. et al. Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase. J Thromb Haemost, 2012; 34 (1):126–31.
16. Iyengar S. S., Nair T., Hiremath J. S. et al. Efficacy and safety of tenecteplase in 6000 patients with ST-elevation myocardial infarction from the Elaxim Indian registry. Indian Heart J, 2011; 63 (1):104–7.
17. Perrott J., Henneberry R. J., Zed P. J. Thrombolysis for cardiac arrest: case report and systematic review of controlled trials. Ann Pharmacother, 2010; 44 (12):2007–13.
Review
For citations:
Taratukhin E.O. Plasminogen activators in acute management of thrombosis. Russian Journal of Cardiology. 2013;(3):81-84. (In Russ.) https://doi.org/10.15829/1560-4071-2013-3-81-84
Views:
711
Email this article 